US EditionAdapting To Funding And Operational Hurdles In Today’s Clinical Trials Landscape - Data Intelligence
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Adapting To Funding And Operational Hurdles In Today’s Clinical Trials Landscape - Data Intelligence
Aditya Kotta, head of business development at Novotech, was one of the experts that discussed the emerging market trends in the early stage biotech landscape at OCT UK & Ireland. Credit: Athanasios Psimadis / Arena International. Events. Against the backdrop of geopolitical tensions and economic measures such as tariffs, which are influencing supply chains across numerous industries, biotech companies are facing significant capital constraints, …
Adapting to funding and operational hurdles in today’s clinical trials landscape
At OCT UK & Ireland, experts provided insights on market trends within the clinical trial industry and advice on engagement strategies.The post Adapting to funding and operational hurdles in today’s clinical trials landscape appeared first on Clinical Trials Arena.
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
